Skip to main content
Clinical Trials/NCT01954199
NCT01954199
Completed
Not Applicable

The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain

Federal University of Health Science of Porto Alegre1 site in 1 country60 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nerve Pain
Sponsor
Federal University of Health Science of Porto Alegre
Enrollment
60
Locations
1
Primary Endpoint
Leg Pain Intensity
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.

Detailed Description

Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain. Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP. Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
April 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Health Science of Porto Alegre
Responsible Party
Principal Investigator
Principal Investigator

Giovanni Esteves Ferreira

Mr

Federal University of Health Science of Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Leg Pain Intensity

Time Frame: Two weeks after randomization

Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS)

Disability

Time Frame: Two weeks after randomization

Disability will be measured by the Oswestry Disability Index (ODI)

Secondary Outcomes

  • Leg pain Intensity(Four weeks after randomization)
  • Disability(Four weeks after randomization)
  • Back pain intensity(Four weeks after randomization)
  • Distribution of Symptoms(Two weeks, Four weeks after randomization)
  • Function(Two weeks, Four weeks after randomization)
  • Global Perceived Effect(Two weeks, Four weeks after randomization)

Study Sites (1)

Loading locations...

Similar Trials